NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-326-2008-0-JP-06 Activators Of Human Pyruvate Kinase JP National Stage 2011-531221 Issued
NIAID E-003-2009-0-PCT-02 Use Of HIV Mosiac Envelope Proteins To Optimize T Cell Responses Against HIV Envelope PCT PCT PCT/US2009/060167 Expired
NCATS E-326-2008-0-PCT-02 Activators Of Human Pyruvate Kinase PCT PCT PCT/US2009/060237 Expired
NCI E-232-2009-0-US-01 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System US 61/249,476 Abandoned
NIAID E-159-2007-3-US-03 Monoclonal Antibodies Against Dengue And Other Viruses With Deletion Of Fc Region US National Stage 12/594,756 8337854 Abandoned PDF
NIAID E-006-2010-0-US-01 Mechanisms For Protection Against Pandemic Strains Of Influenza US 61/248,835 Abandoned
NCI E-010-2008-0-PCT-02 Novel Protein Delivery System For Mammalian Cells PCT PCT PCT/US2009/59328 Expired
NCI E-282-2008-1-PCT-01 Identification Of A Three-gene Expression Signature Predictive Of Response To Cisplatin And Fluorouracil Combination Chemotherapy PCT PCT COMB PCT/US2009/059423 Abandoned
NIAID E-165-2009-0-US-01 Reprogramming Of Somatic Cells By BORIS Gene US 61/248,286 Abandoned
NIDDK E-068-2010-0-US-01 Genotype 1b Hepatitis C Virus Cell Culture System. US 61/248,229 Abandoned
NIAID E-043-2010-0-DK-01 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof DK ORD PA200970143 Abandoned
NICHD E-339-2008-2-CN-02 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia CN National Stage 200980148315.8 Abandoned
NCI E-065-2005-0-US-05 Novobiocin Analogues as Anticancer Agents US CON 12/571,899 7811998 Expired PDF
NICHD E-339-2008-2-PCT-01 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. PCT PCT COMB PCT/US2009/059284 Expired
NICHD E-339-2008-2-EP-03 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. EP National Stage 09818532.5 Abandoned
NICHD E-339-2008-2-IN-04 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. IN National Stage 1382/KOLNP/2011 Abandoned
NCATS E-230-2009-0-US-01 Substituted Quinazolin-4-amine Based Inhibitors Of DyrklA (Dual-specificity Tyrosine-(Y)-phosphorylation Regulated Kinase LA) US 61/247,632 Abandoned
NIDCR E-117-2009-0-US-01 Long-acting Ophthalmic Analgesic Eye Drops US 61/247,881 Abandoned
NCI E-205-2009-0-US-01 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US 61/247,625 Abandoned
NCI E-146-2007-1-US-01 Selenocysteine Mediated Hybrid Antibody Molecules US CIP 12/570,796 8916159 Abandoned PDF
NIA E-241-2008-0-US-03 PHENSERINE AND POSIPHEN FOR TREATING NEUROPSYCHIATRIC AND NEURODEGENERATIVE CONDITIONS US National Stage 13/262,044 Abandoned
NHLBI E-178-2004-0-US-03 Infectious Clone Of Human Parvovirus B19 And Methods US DIV 12/569,848 8603784 Abandoned PDF
NIAID E-158-2007-3-US-02 Live Attenuated Virus Vaccines For La Crosse Virus And Other Bunyaviridae US National Stage 12/593,818 8298541 Abandoned PDF
NCI E-206-1995-3-US-13 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY US DIV 12/569,821 7939639 Abandoned PDF
NCI E-090-2000-1-US-07 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 US DIV 12/568,134 8754046 Expired PDF
NIAID E-005-2009-1-PCT-01 Flavivirus-Based System For Production Of Hepatitis C Virus (HCV) PCT PCT COMB PCT/US09/58598 Expired
NCI E-051-2009-0-PCT-02 LARGE-SCALE PROTEIN SAMPLE COLLECTION METHOD PCT PCT PCT/JP2009/066811 Expired
NLM E-107-2010-2-PCT-01 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS PCT PCT COMB PCT/US2009/058562 Expired
NIMH E-245-2006-0-US-03 Schizophrenia-Related Isoform Of KCNH2 For The Development Of Antipsychotic Drugs US National Stage 12/593,159 8101380 Abandoned PDF
NIAID E-341-2008-0-PCT-02 Method For Boosting Immunity To Influenza Vaccine PCT PCT PCT/US2009/58464 Expired
NCI E-314-2008-0-PCT-02 Prediction Of Survival In Colon Adenocarcinoma Using The Expression Of Inflammatory Genes And MicroRNA21 PCT PCT PCT/US09/058425 Expired
NIAID E-300-2009-0-US-01 Neutralizing Antibodies to HIV-1 and Their Use US 61/246,039 Abandoned
NHLBI E-290-2009-0-US-01 Three Dimensional Motion Tracking From Volumetric Data US 61/245,586 Abandoned
NIAID E-123-2007-0-IT-30 Monoclonal Antibodies That Neutralize Anthrax Toxin IT EP 08730415.0 Abandoned
NIAID E-123-2007-0-IE-29 Monoclonal Antibodies That Neutralize Anthrax Toxin IE EP 08730415.0 Abandoned
NIAID E-123-2007-0-SE-32 Monoclonal Antibodies That Neutralize Anthrax Toxin SE EP 08730415.0 Abandoned
NIAID E-123-2007-0-GB-28 Monoclonal Antibodies That Neutralize Anthrax Toxin GB EP 08730415.0 Abandoned
NIAID E-123-2007-0-CH-25 Monoclonal Antibodies That Neutralize Anthrax Toxin CH EP 08730415.0 Abandoned
NIAID E-123-2007-0-FR-27 Monoclonal Antibodies That Neutralize Anthrax Toxin FR EP 08730415.0 Abandoned
NIAID E-123-2007-0-DE-26 Monoclonal Antibodies That Neutralize Anthrax Toxin DE EP 08730415.0 Abandoned
NIAID E-123-2007-0-LI-31 Monoclonal Antibodies That Neutralize Anthrax Toxin LI EP 08730415.0 Abandoned
NCI E-204-2009-0-US-01 Compositions and Methods for Silencing Genes Expressed in Cancer US 61/245,143 Abandoned
NCATS E-188-2009-0-US-01 Inhibitors Of Tau Protein Fibrillization. US 61/245,045 Abandoned
NCI E-256-2006-0-US-11 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs US National Stage 12/513,950 9326950 Issued PDF
NCI E-006-2000-0-US-05 RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS US DIV 12/564,702 8012490 Expired PDF
NCI E-295-2008-0-PCT-02 Novel Inhibitor Of NFkB PCT PCT PCT/US09/57761 Expired
NCI E-295-2008-0-EP-03 Nuclear Factor Kappa B Pathway Inhibitor Composition And Use Of Same EP National Stage 09792812.1 Abandoned
NCI E-221-2005-2-US-01 Fast Electron Paramagnetic Resonance Imaging (EPRI) Using CW CPR Spectrometer With Sinusoidal Rapid-scan And Digital Signal Processing US CIP 12/564,006 Abandoned
NCI E-295-2009-0-US-01 Method for Predicting of Patient Immune Responses Outcome To Treatment With Keyhole Limpet Hemocyanin US 61/243,849 Abandoned
NIAID E-083-2006-0-US-03 Newly Discovered Bacterium In The Family Acetobacteraceae US ORD 12/225,615 9051573 Issued PDF